Qualia: Like TianChi, the nootropic blend Qualia is a “shotgun” approach, providing over forty-two different ingredients, including a host of herbal adaptogens, brain vitamins, amino acids, choline donors, anti-inflammatories and antioxidants too long to list here (you can view the full ingredient profile here). Unlike TianChi, it also contains synthetic nootropic “noopept”, which has about 1,000 times the potency of piracetam, along with a few other helpful ingredients, including curcumin and bioperine, and slightly higher amounts of caffeine. It also requires two daily dosing protocols: with the first dose taken on an empty stomach and the second with a meal (for those compounds better absorbed with food). For those who prefer to skip on the synthetic nootropic, get most of the compounds at slightly lower price point (Qualia is admittedly quite expensive at $150 for the two dosing bottles), and also get the addition of the Indian plant you learned about earlier called “Celastrus paniculatus”, there is a very similar supplement made by the same manufacturer called “Qualia Mind”.
Evidence in support of the neuroprotective effects of flavonoids has increased significantly in recent years, although to date much of this evidence has emerged from animal rather than human studies. Nonetheless, with a view to making recommendations for future good practice, we review 15 existing human dietary intervention studies that have examined the effects of particular types of flavonoid on cognitive performance. The studies employed a total of 55 different cognitive tests covering a broad range of cognitive domains. Most studies incorporated at least one measure of executive function/working memory, with nine reporting significant improvements in performance as a function of flavonoid supplementation compared to a control group. However, some domains were overlooked completely (e.g. implicit memory, prospective memory), and for the most part there was little consistency in terms of the particular cognitive tests used making across study comparisons difficult. Furthermore, there was some confusion concerning what aspects of cognitive function particular tests were actually measuring. Overall, while initial results are encouraging, future studies need to pay careful attention when selecting cognitive measures, especially in terms of ensuring that tasks are actually sensitive enough to detect treatment effects.
At this point, I discovered I had run out of magnesium pills and had forgotten to order the magnesium citrate powder I’d intended to. I still had a lot of Noopept pills for the concurrently running second Noopept self-experiment, but since I wanted to wrap up some other experiments with a big analysis at the end of the year, I decided to halt and resume in January 2014.
The use of cognition-enhancing drugs by healthy individuals in the absence of a medical indication spans numerous controversial issues, including the ethics and fairness of their use, concerns over adverse effects, and the diversion of prescription drugs for nonmedical uses, among others. Nonetheless, the international sales of cognition-enhancing supplements exceeded US$1 billion in 2015 when global demand for these compounds grew.